Invention Grant
US08592466B2 Methods for treating conditions caused by higher-than-normal dopaminergic activity in basal ganglia
有权
治疗由基底神经节高于正常多巴胺能活性引起的病症的方法
- Patent Title: Methods for treating conditions caused by higher-than-normal dopaminergic activity in basal ganglia
- Patent Title (中): 治疗由基底神经节高于正常多巴胺能活性引起的病症的方法
-
Application No.: US13552182Application Date: 2012-07-18
-
Publication No.: US08592466B2Publication Date: 2013-11-26
- Inventor: Ahmed Elkashef
- Applicant: Ahmed Elkashef
- Applicant Address: US VA Dunn Loring
- Assignee: Neuropill, Inc.
- Current Assignee: Neuropill, Inc.
- Current Assignee Address: US VA Dunn Loring
- Agency: The Marbury Law Group, PLLC
- Main IPC: A01N43/78
- IPC: A01N43/78 ; A61K31/425 ; A01N43/26 ; A61K31/385 ; A01N43/06 ; A61K31/38 ; A01N47/28 ; A61K31/17
Abstract:
Treatment of humans suffering from conditions caused by higher-than-normal dopaminergic activity in basal ganglia includes administering the compound (2S)-2-{3-[3-({[(2R,4R)-4-tert-Butoxycarbonyl-2-(2-fluorophenyl)]-3-thiazolidinyl}carbonylmethyl)ureido]phenyl}propionic acid and its physiological acceptable salts.
Public/Granted literature
- US20120289556A1 Methods for Treating Conditions Caused by Higher-Than-Normal Dopaminergic Activity In Basal Ganglia Public/Granted day:2012-11-15
Information query
IPC分类:
